Aminopterin was later marketed by Lederle Laboratories (Pearl River, New York) in the United States from 1953 to 1964 for the indication of pediatric leukemia.
Aminopterin je kasnije prodavala kompanija Lederle Laboratories (Pearl River, Njujork) u SAD od 1953 do 1964 za pedijatrijsku leukemiju.